Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Children’s Motrin lawsuit

This article was originally published in The Tan Sheet

Executive Summary

McNeil Consumer & Specialty Pharmaceuticals is "aware of the report of a seven-year-old girl who has been diagnosed with Stevens-Johnson syndrome, allegedly associated with the use of Children's Motrin," the Johnson & Johnson subsidiary said, responding to a lawsuit filed in Los Angeles Superior Court Dec. 28. The firm said it is "investigating the situation." Seven-year-old Sabrina Brierton Johnson is suing J&J, McNeil, McKesson Corp., Save-On Drug Stores, Cardinal Health and Ralph's Grocery for selling the ibuprofen oral suspension knowing an allergic reaction to the drug could trigger the skin disease Stevens-Johnson syndrome, which in turn may cause blindness. Timing of the suit comes amidst increasing concerns about drug safety, and closely follows the addition of a black box warning mentioning risk of skin diseases, including Stevens-Johnson syndrome, to Pfizer's COX-2 inhibitor Bextra...

You may also be interested in...

Children’s Motrin Suit Seeks Compensation, New Label For Ibuprofen Product

A lawsuit that alleges Children's Motrin with ibuprofen caused a girl's blindness wants McNeil Consumer & Specialty Pharmaceuticals to clearly list all potential serious adverse reactions on the product's label and compensate the child

GNC In Rough Seas From COVID-19 Pandemic; Vitamin Shoppe Safe In Port Under New Owner

GNC announces "significant" store and management staff furloughs and other cost-cutting moves "to protect the long-term prospects for the business." Vitamin Shoppe told customers that its stores remain open though it reduced business hours.

QUOTED. 7 April 2020. Surendar Magar.

California-based biosensor patch company LifeSignals Group plans to file for an emergency use authorization from the US FDA for a new patch that can monitor vital signs to help individuals decide when to seek the help of a health care provider. See what LifeSignals’ CEO Surendar Magar said about it here.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts